Direct binding of neutral endopeptidase 24.11 to ezrin/radixin/moesin (ERM) proteins competes with the interaction of CD44 with ERM proteins.
about
Structural basis for type II membrane protein binding by ERM proteins revealed by the radixin-neutral endopeptidase 24.11 (NEP) complexEzrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epitheliaCharacterization of a novel interaction between ELMO1 and ERM proteins.Casein kinase 2 dependent phosphorylation of neprilysin regulates receptor tyrosine kinase signaling to AktNeprilysin impedes islet amyloid formation by inhibition of fibril formation rather than peptide degradation.Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.Role of neprilysin in airway inflammation induced by diesel exhaust emissions.Possible involvement of CD10 in the development of endometriosis due to its inhibitory effects on CD44-dependent cell adhesion.Merlin and the ERM proteins--regulators of receptor distribution and signaling at the cell cortex.Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer.Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.Ezrin/radixin/moesin are required for the purinergic P2X7 receptor (P2X7R)-dependent processing of the amyloid precursor protein.Neprilysin inhibits angiogenesis via proteolysis of fibroblast growth factor-2.Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase.Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18.Crystallographic characterization of the radixin FERM domain bound to the cytoplasmic tails of adhesion molecules CD43 and PSGL-1Crystallographic characterization of the radixin FERM domain bound to the cytoplasmic tail of membrane-type 1 matrix metalloproteinase (MT1-MMP)Crystallographic characterization of the radixin FERM domain bound to the cytoplasmic tail of adhesion molecule CD44.Rational redesign of neutral endopeptidase binding to merlin and moesin proteins.Negative regulation of NEP expression by hypoxia.Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer.
P2860
Q27644609-DA9C7624-4C36-40C4-AF21-66524E56694EQ28588034-972CAE38-C12F-4252-A970-E41005F114ACQ30439052-4253E84B-9C9A-4BB5-A922-54753FC3D0A9Q33721897-EAAB54E3-6AF4-4676-AB51-A0E2BDD12837Q33897696-CAACB5FC-D03E-4EC8-87A3-3A4ED0EA3BCFQ34777829-162F51EA-0F24-4FFE-90E4-7E0010DD1B53Q36575175-F0C36764-237C-419D-B6E4-FA544270CD81Q37379796-95EF415B-2D1A-4AA9-AA89-4048243BC583Q37432747-4AF12EE7-D3A8-4142-899F-57131CDFD196Q37855740-A2C052A5-99C7-488E-B7F7-82564351E1FAQ39297022-FF7DAE87-AF96-4917-BB58-5399C35FF454Q39297821-462B3395-868F-46B5-8D05-2D97FB19AC62Q40238484-C13D797B-2BAD-468F-A6AB-03EF8AEE2A1FQ40284709-2F6162DF-21E5-473F-8E3F-CC60334E9098Q40563114-9785D76E-F745-4F63-A7E0-AFEA3DF52D01Q41834384-3B2A217B-8E80-46DB-92D8-FA324FCD04FEQ42001090-A584D81F-3D12-4007-9BBD-DB301BBC54F3Q42001296-2FAB9574-E207-49A2-8EEF-C7D1D40E3B69Q42606516-62329FD9-012C-444A-83FE-FFCA95F85B7CQ42714368-C76055BE-A3B7-44A9-A729-3534DC922DBBQ46557742-5D537739-FE65-4BF2-AA11-99A7C9AE7E82
P2860
Direct binding of neutral endopeptidase 24.11 to ezrin/radixin/moesin (ERM) proteins competes with the interaction of CD44 with ERM proteins.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Direct binding of neutral endo ...... ion of CD44 with ERM proteins.
@en
type
label
Direct binding of neutral endo ...... ion of CD44 with ERM proteins.
@en
prefLabel
Direct binding of neutral endo ...... ion of CD44 with ERM proteins.
@en
P2093
P2860
P356
P1476
Direct binding of neutral endo ...... ion of CD44 with ERM proteins.
@en
P2093
Akira Iwase
Daniel Navarro
David M Nanus
Ruoqian Shen
P2860
P304
11898-11905
P356
10.1074/JBC.M212737200
P407
P577
2004-01-02T00:00:00Z